[Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium]
- PMID: 19082568
- DOI: 10.1007/s00101-008-1455-2
[Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium]
Abstract
Up to now only acetylcholine esterase inhibitors, such as neostigmine, were available as antagonists of residual neuromuscular blocks. Sugammadex is a modified gamma-cyclodextrin that binds rocuronium and chemically similar aminosteroidal muscle relaxants, such as vecuronium. The underlying mechanism of action is new and differs completely from that of acetylcholine esterase inhibitors. This review summarizes data published so far within the framework of the licensing procedure about the efficacy, safety and side-effects of sugammadex and presents potential new anesthesiological concepts using this compound.
Similar articles
-
A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.Anesth Analg. 2010 Jan 1;110(1):74-82. doi: 10.1213/ANE.0b013e3181c3be3c. Epub 2009 Nov 21. Anesth Analg. 2010. PMID: 19933538 Clinical Trial.
-
Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.Anesthesiology. 2007 Feb;106(2):283-8. doi: 10.1097/00000542-200702000-00016. Anesthesiology. 2007. PMID: 17264722 Clinical Trial.
-
Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.Br J Anaesth. 2008 Mar;100(3):373-9. doi: 10.1093/bja/aem402. Epub 2008 Jan 31. Br J Anaesth. 2008. PMID: 18238834 Clinical Trial.
-
[Sugammadex, a novel drug for neuromuscular blockade reversal].Rev Esp Anestesiol Reanim. 2010 Feb;57(2):95-102. doi: 10.1016/s0034-9356(10)70171-7. Rev Esp Anestesiol Reanim. 2010. PMID: 20337001 Review. Spanish.
-
Sugammadex: a selective relaxant-binding agent providing rapid reversal.Curr Opin Anaesthesiol. 2010 Aug;23(4):461-5. doi: 10.1097/ACO.0b013e32833a5413. Curr Opin Anaesthesiol. 2010. PMID: 20489603 Review.
Cited by
-
[Implantation of cardioverter-defibrillators. How much anesthesia is necessary?].Anaesthesist. 2010 Jun;59(6):507-18. doi: 10.1007/s00101-010-1737-3. Anaesthesist. 2010. PMID: 20458452 Review. German.
-
[Update on muscle relaxation : What comes after succinylcholine, rocuronium and sugammadex?].Anaesthesist. 2017 May;66(5):353-359. doi: 10.1007/s00101-017-0289-1. Anaesthesist. 2017. PMID: 28289767 Review. German.
-
Investigation of proarrhythmic effect of high sugammadex doses: an experimental animal study.J Anesth Analg Crit Care. 2022 Dec 23;2(1):53. doi: 10.1186/s44158-022-00077-0. J Anesth Analg Crit Care. 2022. PMID: 37386607 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources